IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1372-1384

  Mizutani, Nobuaki ^a   Nabe, Takeshi ^b   Yoshino, Shin ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5;

AIRWAY OBSTRUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE EXACERBATION; GOBLET CELL; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CHEMOKINE CXCL5; EOSINOPHILS; GOBLET CELLS; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKINS; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; RECEPTORS, INTERLEUKIN-8B; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 84896711467     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301538     Document Type: Article

References (60)

1. Cohn, L., J. A. Elias, and G. L. Chupp. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22: 789-815.
2. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304.
3. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
4. Pauwels, R. 1989. The relationship between airway inflammation and bronchial hyperresponsiveness. Clin. Exp. Allergy 19: 395-398.
5. Bousquet, J., P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. 2000. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161: 1720-1745.
6. Jatakanon, A., C. Uasuf, W. Maziak, S. Lim, K. F. Chung, and P. J. Barnes. 1999. Neutrophilic inflammation in severe persistent asthma. Am. J. Respir. Crit. Care Med. 160: 1532-1539.
7. Louis, R., L. C. Lau, A. O. Bron, A. C. Roldaan, M. Radermecker, and R. Djukanović. 2000. The relationship between airways inflammation and asthma severity. Am. J. Respir. Crit. Care Med. 161: 9-16.
8. Hogan, S. P., K. I. Matthaei, J. M. Young, A. Koskinen, I. G. Young, and P. S. Foster. 1998. A novel T cell-regulated mechanism modulating allergeninduced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 161: 1501-1509.
9. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
10. De Sanctis, G. T., A. Itoh, F. H. Green, S. Qin, T. Kimura, J. K. Grobholz, T. R. Martin, T. Maki, and J. M. Drazen. 1997. T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat. Med. 3: 460-462.
11. Kurowska-Stolarska, M., P. Kewin, G. Murphy, R. C. Russo, B. Stolarski, C. C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, W. Niedbala, et al. 2008. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. [Published erratum appears in 2008 J. Immunol. 181: 8170.] J. Immunol. 181: 4780-4790.
12. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
13. Kearley, J., K. F. Buckland, S. A. Mathie, and C. M. Lloyd. 2009. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am. J. Respir. Crit. Care Med. 179: 772-781.
14. Al-Ramli, W., D. Préfontaine, F. Chouiali, J. G. Martin, R. Olivenstein, C. Lemière, and Q. Hamid. 2009. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy Clin. Immunol. 123: 1185-1187.
15. Barczyk, A., W. Pierzchala, and E. Sozañska. 2003. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97: 726-733.
16. He, R., M. K. Oyoshi, H. Jin, and R. S. Geha. 2007. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc. Natl. Acad. Sci. USA 104: 15817-15822.
17. Lajoie, S., I. P. Lewkowich, Y. Suzuki, J. R. Clark, A. A. Sproles, K. Dienger, A. L. Budelsky, and M. Wills-Karp. 2010. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11: 928-935.
18. Konrad, F. M., and J. Reutershan. 2012. CXCR2 in acute lung injury. Mediators Inflamm. 2012: 740987.
19. Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13: 159-175.
20. Del Rio, L., S. Bennouna, J. Salinas, and E. Y. Denkers. 2001. CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J. Immunol. 167: 6503-6509.
21. Kielian, T., B. Barry, and W. F. Hickey. 2001. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J. Immunol. 166: 4634-4643.
22. Knott, P. G., P. R. Gater, P. J. Dunford, M. E. Fuentes, and C. P. Bertrand. 2001. Rapid up-regulation of CXC chemokines in the airways after Ag-specific CD4+ T cell activation. J. Immunol. 166: 1233-1240.
23. Zhong, B., X. Liu, X. Wang, S. H. Chang, X. Liu, A. Wang, J. M. Reynolds, and C. Dong. 2012. Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat. Immunol. 13: 1110-1117.
24. Bulek, K., C. Liu, S. Swaidani, L. Wang, R. C. Page, M. F. Gulen, T. Herjan, A. Abbadi, W. Qian, D. Sun, et al. 2011. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat. Immunol. 12: 844-852.
25. Qiu, Y., J. Zhu, V. Bandi, K. K. Guntupalli, and P. K. Jeffery. 2007. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 62: 475-482.
26. Gibson, P. G., J. L. Simpson, and N. Saltos. 2001. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119: 1329-1336.
27. Nair, P., M. Gaga, E. Zervas, K. Alagha, F. E. Hargreave, P. M. O'Byrne, P. Stryszak, L. Gann, J. Sadeh, and P. Chanez; Study Investigators. 2012. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin. Exp. Allergy 42: 1097-1103.
28. Mizutani, N., H. Goshima, T. Nabe, and S. Yoshino. 2012. Establishment and characterization of a murine model for allergic asthma using allergen-specific IgE monoclonal antibody to study pathological roles of IgE. Immunol. Lett. 141: 235-245.
29. Mizutani, N., H. Goshima, T. Nabe, and S. Yoshino. 2012. Complement C3ainduced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice. J. Immunol. 188: 5694-5705.
30. Mizutani, N., T. Nabe, and S. Yoshino. 2013. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgEmediated airway inflammation and remodelling in mice. Immunology 139: 205-218.
31. Nabe, T., F. Hosokawa, K. Matsuya, T. Morishita, A. Ikedo, M. Fujii, N. Mizutani, S. Yoshino, and D. D. Chaplin. 2011. Important role of neutrophils in the late asthmatic response in mice. Life Sci. 88: 1127-1135.
32. Mizutani, N., T. Nabe, and S. Yoshino. 2009. Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. J. Immunol. 183: 4039-4046.
33. Pennock, B. E., C. P. Cox, R. M. Rogers, W. A. Cain, and J. H. Wells. 1979. A noninvasive technique for measurement of changes in specific airway resistance. J. Appl. Physiol. 46: 399-406.
34. Bedoret, D., H. Wallemacq, T. Marichal, C. Desmet, F. Quesada Calvo, E. Henry, R. Closset, B. Dewals, C. Thielen, P. Gustin, et al. 2009. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J. Clin. Invest. 119: 3723-3738.
35. Liu, Y., J. Mei, L. Gonzales, G. Yang, N. Dai, P. Wang, P. Zhang, M. Favara, K. C. Malcolm, S. Guttentag, and G. S. Worthen. 2011. IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J. Immunol. 186: 3197-3205.
36. Fielding, C. A., R. M. McLoughlin, L. McLeod, C. S. Colmont, M. Najdovska, D. Grail, M. Ernst, S. A. Jones, N. Topley, and B. J. Jenkins. 2008. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J. Immunol. 181: 2189-2195.
37. Taube, C., A. Dakhama, Y. H. Rha, K. Takeda, A. Joetham, J. W. Park, A. Balhorn, T. Takai, K. R. Poch, J. A. Nick, and E. W. Gelfand. 2003. Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors. J. Immunol. 170: 4301-4309.
38. Le, H. T., V. G. Tran, W. Kim, J. Kim, H. R. Cho, and B. Kwon. 2012. IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals. J. Immunol. 189: 287-295.
39. Leckie, M. J., A. ten Brinke, J. Khan, Z. Diamant, B. J. O'Connor, C. M. Walls, A. K. Mathur, H. C. Cowley, K. F. Chung, R. Djukanovic, et al. 2000. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356: 2144-2148.
40. Louis, R., and R. Djukanovic. 2006. Is the neutrophil a worthy target in severe asthma and chronic obstructive pulmonary disease? Clin. Exp. Allergy 36: 563-567.
41. Wenzel, S. E., S. J. Szefler, D. Y. Leung, S. I. Sloan, M. D. Rex, and R. J. Martin. 1997. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am. J. Respir. Crit. Care Med. 156: 737-743.
42. Green, R. H., C. E. Brightling, G. Woltmann, D. Parker, A. J. Wardlaw, and I. D. Pavord. 2002. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57: 875-879.
43. Salmond, R. J., A. S. Mirchandani, A. G. Besnard, C. C. Bain, N. C. Thomson, and F. Y. Liew. 2012. IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin. J. Allergy Clin. Immunol. 130: 1159-1166, e6.
44. Kamijo, S., H. Takeda, T. Tokura, M. Suzuki, K. Inui, M. Hara, H. Matsuda, A. Matsuda, K. Oboki, T. Ohno, et al. 2013. IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergeninduced allergic airway inflammation. J. Immunol. 190: 4489-4499.
45. Little, S. A., K. J. MacLeod, G. W. Chalmers, J. G. Love, C. McSharry, and N. C. Thomson. 2002. Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am. J. Med. 112: 446-452.
46. Biffl, W. L., E. E. Moore, F. A. Moore, and C. C. Barnett, Jr. 1995. Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. J. Leukoc. Biol. 58: 582-584.
47. Ward, P. A. 1996. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann. N. Y. Acad. Sci. 796: 104-112.
48. Lentsch, A. B., B. J. Czermak, N. M. Bless, N. Van Rooijen, and P. A. Ward. 1999. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Am. J. Respir. Cell Mol. Biol. 20: 692-698.
49. Koltsova, E. K., and K. Ley. 2010. The mysterious ways of the chemokine CXCL5. Immunity 33: 7-9.
50. McKinley, L., J. F. Alcorn, A. Peterson, R. B. Dupont, S. Kapadia, A. Logar, A. Henry, C. G. Irvin, J. D. Piganelli, A. Ray, and J. K. Kolls. 2008. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181: 4089-4097.
51. Ano, S., Y. Morishima, Y. Ishii, K. Yoh, Y. Yageta, S. Ohtsuka, M. Matsuyama, M. Kawaguchi, S. Takahashi, and N. Hizawa. 2013. Transcription factors GATA-3 and RORγt are important for determining the phenotype of allergic airway inflammation in a murine model of asthma. J. Immunol. 190: 1056-1065.
52. Oakley, R. H., M. Sar, and J. A. Cidlowski. 1996. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271: 9550-9559.
53. Vazquez-Tello, A., A. Semlali, J. Chakir, J. G. Martin, D. Y. Leung, D. H. Eidelman, and Q. Hamid. 2010. Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin. Exp. Allergy 40: 1312-1322.
54. Rankin, J. A., D. E. Picarella, G. P. Geba, U. A. Temann, B. Prasad, B. DiCosmo, A. Tarallo, B. Stripp, J. Whitsett, and R. A. Flavell. 1996. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA 93: 7821-7825.
55. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788.
56. Doganci, A., T. Eigenbrod, N. Krug, G. T. De Sanctis, M. Hausding, V. J. Erpenbeck, B. Haddad, H. A. Lehr, E. Schmitt, T. Bopp, et al. 2005. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. [Published erratum appears in 2005 J. Clin. Invest. 115: 1388.] J. Clin. Invest. 115: 313-325.
57. Chen, Y., P. Thai, Y. H. Zhao, Y. S. Ho, M. M. DeSouza, and R. Wu. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278: 17036-17043.
58. Busse, W., J. Corren, B. Q. Lanier, M. McAlary, A. Fowler-Taylor, G. D. Cioppa, A. van As, and N. Gupta. 2001. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J. Allergy Clin. Immunol. 108: 184-190.
59. Holgate, S., T. Casale, S. Wenzel, J. Bousquet, Y. Deniz, and C. Reisner. 2005. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J. Allergy Clin. Immunol. 115: 459-465.
60. Holgate, S. T., A. G. Chuchalin, J. Hébert, J. Lötvall, G. B. Persson, K. F. Chung, J. Bousquet, H. A. Kerstjens, H. Fox, J. Thirlwell, and G. D. Cioppa; Omalizumab 011 International Study Group. 2004. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin. Exp. Allergy 34: 632-638.